WallStreetZenWallStreetZen

NASDAQ: AXNX
Axonics Inc Stock

$67.80-0.13 (-0.19%)
Updated Jul 12, 2024
AXNX Price
$67.80
Fair Value Price
N/A
Market Cap
$3.46B
52 Week Low
$48.30
52 Week High
$69.68
P/E
-218.71x
P/B
5.52x
P/S
9.07x
PEG
N/A
Dividend Yield
N/A
Revenue
$387.14M
Earnings
-$15.95M
Gross Margin
75.2%
Operating Margin
-3.6%
Profit Margin
-4.1%
Debt to Equity
0.14
Operating Cash Flow
-$10M
Beta
1.17
Next Earnings
Jul 25, 2024
Ex-Dividend
N/A
Next Dividend
N/A

AXNX Overview

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AXNX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AXNX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AXNX is poor value based on its book value relative to its share price (5.52x), compared to the US Medical Devices industry average (3.89x)
P/B vs Industry Valuation
AXNX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more AXNX due diligence checks available for Premium users.

Be the first to know about important AXNX news, forecast changes, insider trades & much more!

AXNX News

Valuation

AXNX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-218.71x
Industry
30.59x
Market
32.2x

AXNX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.52x
Industry
3.89x
AXNX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AXNX's financial health

Profit margin

Revenue
$91.4M
Net Income
-$19.1M
Profit Margin
-20.9%
AXNX's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
AXNX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$715.6M
Liabilities
$88.5M
Debt to equity
0.14
AXNX's short-term assets ($482.03M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AXNX's short-term assets ($482.03M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AXNX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AXNX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$9.2M
Investing
$138.2M
Financing
$248.0k
AXNX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AXNX vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
AXNX$3.46B-0.19%-218.71x5.52x
PRCT$3.57B+1.50%-32.71x13.51x
NARI$3.16B+2.22%-136.03x7.07x
IRTC$2.99B-1.13%-22.74x33.14x
TNDM$2.98B+1.83%-21.23x12.24x

Axonics Stock FAQ

What is Axonics's quote symbol?

(NASDAQ: AXNX) Axonics trades on the NASDAQ under the ticker symbol AXNX. Axonics stock quotes can also be displayed as NASDAQ: AXNX.

If you're new to stock investing, here's how to buy Axonics stock.

What is the 52 week high and low for Axonics (NASDAQ: AXNX)?

(NASDAQ: AXNX) Axonics's 52-week high was $69.68, and its 52-week low was $48.30. It is currently -2.7% from its 52-week high and 40.37% from its 52-week low.

How much is Axonics stock worth today?

(NASDAQ: AXNX) Axonics currently has 51,018,478 outstanding shares. With Axonics stock trading at $67.80 per share, the total value of Axonics stock (market capitalization) is $3.46B.

Axonics stock was originally listed at a price of $14.98 in Oct 31, 2018. If you had invested in Axonics stock at $14.98, your return over the last 5 years would have been 352.6%, for an annualized return of 35.25% (not including any dividends or dividend reinvestments).

How much is Axonics's stock price per share?

(NASDAQ: AXNX) Axonics stock price per share is $67.80 today (as of Jul 12, 2024).

What is Axonics's Market Cap?

(NASDAQ: AXNX) Axonics's market cap is $3.46B, as of Jul 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Axonics's market cap is calculated by multiplying AXNX's current stock price of $67.80 by AXNX's total outstanding shares of 51,018,478.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.